Howell K E, Palade G E
J Cell Biol. 1982 Mar;92(3):833-45. doi: 10.1083/jcb.92.3.833.
Newly synthesized phospholipids, labeled with either [14C]choline, [3H]myo-inositol, or [33P]phosphate, partioned preferentially (greater than 80% of total incorporated radioactivity) in a Golgi membrane subfraction, although the cognate content subfraction contained a relatively large amount of secretory lipoproteins. The labeling pattern was the same for all phospholipids tested in the two subfractions. An active exchange process of polar lipids between Golgi membranes and Golgi secretory lipoproteins is postulated as a plausible explanation for these findings. Less than half of all Golgi lipoprotein particles have the density of serum VLDLs and a similar, but not identical, biochemical composition. The remaining lipoprotein particles are characterized by a continuous spectrum of sizes, and (to the extent tested) by a lipid and protein composition different from that of serum VLDLs and HDLs. Results obtained in control experiments rule out the possibility that the heterogeneous population of Golgi lipoprotein particles is an artefact caused by our preparation procedures. It is assumed that these heterogeneous particles are immature precursors of both VLDLs and HDLs.
新合成的磷脂,用[14C]胆碱、[3H]肌醇或[33P]磷酸盐标记,优先分配(占总掺入放射性的80%以上)到高尔基体膜亚组分中,尽管同源含量亚组分含有相对大量的分泌性脂蛋白。在两个亚组分中测试的所有磷脂的标记模式相同。推测高尔基体膜和高尔基体分泌性脂蛋白之间存在极性脂质的活跃交换过程,以此作为这些发现的合理解释。所有高尔基体脂蛋白颗粒中,不到一半具有血清极低密度脂蛋白(VLDL)的密度,且具有相似但不完全相同的生化组成。其余的脂蛋白颗粒具有连续的大小谱,并且(在所测试的范围内)其脂质和蛋白质组成与血清VLDL和高密度脂蛋白(HDL)不同。对照实验的结果排除了高尔基体脂蛋白颗粒异质性群体是由我们的制备程序导致的假象的可能性。假定这些异质性颗粒是VLDL和HDL的不成熟前体。